$MAXM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MAXIM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MAXIM PHARMACEUTICALS INC. Get notifications about new insider transactions in MAXIM PHARMACEUTICALS INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | D | 1.64 | 20,000 | 32,800 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | D | 7.06 | 6,250 | 44,125 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | D | 7.06 | 6,250 | 44,125 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | D | 9.60 | 18,750 | 180,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | D | 9.60 | 23,750 | 228,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Bedard John F | Director | Option Exercise | D | 1.64 | 24,375 | 39,975 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Bedard John F | Director | Option Exercise | D | 1.64 | 25,000 | 41,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Bedard John F | Director | Option Exercise | D | 2.72 | 3,125 | 8,500 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 9.25 | 5,000 | 46,250 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 5.20 | 30,000 | 156,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 15.75 | 15,000 | 236,250 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 3.75 | 40,000 | 150,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 1.64 | 20,000 | 32,800 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 3.25 | 20,000 | 65,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 9.60 | 20,000 | 192,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 9.60 | 20,000 | 192,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 5.73 | 20,000 | 114,600 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 6.94 | 20,000 | 138,800 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 6.94 | 20,000 | 138,800 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 8.00 | 50,000 | 400,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 72.50 | 10,000 | 725,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 37.00 | 20,000 | 740,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Sell | D | 0.00 | 333 | 0 | 0 | 333 to 0 (-100.00 %) |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Option Exercise | D | 5.82 | 5,000 | 29,100 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Option Exercise | D | 5.05 | 15,000 | 75,750 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Option Exercise | D | 1.77 | 50,000 | 88,500 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Option Exercise | D | 2.30 | 100,000 | 230,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Option Exercise | D | 6.72 | 5,000 | 33,600 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Option Exercise | D | 2.86 | 5,000 | 14,300 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Sell | D | 0.00 | 4,042 | 0 | 0 | 4 K to 0 (-100.00 %) |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 5.20 | 45,000 | 234,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 11.44 | 5,000 | 57,200 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 15.75 | 5,000 | 78,750 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 8.88 | 10,000 | 88,800 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 1.64 | 20,000 | 32,800 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 9.60 | 20,000 | 192,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 5.73 | 20,000 | 114,600 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 6.94 | 20,000 | 138,800 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 8.00 | 50,000 | 400,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 72.50 | 15,000 | 1,087,500 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 72.50 | 10,000 | 725,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 37.00 | 20,000 | 740,000 | 0 | |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Sell | D | 0.00 | 790 | 0 | 0 | 790 to 0 (-100.00 %) |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Sell | D | 0.00 | 71,228 | 0 | 0 | 71.2 K to 0 (-100.00 %) |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Jan 06 2006 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Sell | D | 0.00 | 3,657 | 0 | 0 | 3.7 K to 0 (-100.00 %) |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 1.63 | 150,000 | 244,500 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 8.94 | 125,000 | 1,117,500 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 6.72 | 100,000 | 672,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 2.13 | 1,091 | 2,324 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 2.13 | 73,909 | 157,426 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 2.13 | 375,000 | 798,750 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 5.20 | 50,000 | 260,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 5.20 | 50,000 | 260,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 6.94 | 42,348 | 293,895 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 6.94 | 7,652 | 53,105 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 6.94 | 50,000 | 347,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 37.00 | 100,000 | 3,700,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 37.00 | 100,000 | 3,700,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 8.00 | 100,000 | 800,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 12.88 | 75,000 | 966,000 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 14.50 | 55,750 | 808,375 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 14.50 | 24,584 | 356,468 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Option Exercise | D | 9.00 | 83,333 | 749,997 | 0 | |
Aug 05 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman,CEO and Pr ... | Sell | D | 1.46 | 203,333 | 296,866 | 0 | 203.3 K to 0 (-100.00 %) |
Apr 12 2005 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, CEO, Pres ... | Option Exercise | A | 1.63 | 150,000 | 244,500 | 150,000 | |
Feb 22 2005 | MAXM | MAXIM PHARMACEUTIC ... | Bedard John F | Director | Option Exercise | A | 1.64 | 25,000 | 41,000 | 25,000 | |
Feb 22 2005 | MAXM | MAXIM PHARMACEUTIC ... | Bedard John F | Director | Option Exercise | A | 1.64 | 24,375 | 39,975 | 24,375 | |
Feb 22 2005 | MAXM | MAXIM PHARMACEUTIC ... | ZERBE ROBERT L MD | Director | Option Exercise | A | 1.64 | 20,000 | 32,800 | 20,000 | |
Feb 22 2005 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | A | 1.64 | 20,000 | 32,800 | 20,000 | |
Mar 10 2005 | MAXM | MAXIM PHARMACEUTIC ... | Prunty John D | Chief Financial Off ... | Option Exercise | A | 1.77 | 50,000 | 88,500 | 50,000 | |
Feb 22 2005 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | A | 1.64 | 20,000 | 32,800 | 20,000 | |
Feb 22 2005 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 1.64 | 20,000 | 32,800 | 20,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TONETTA SHARON A | VP Drug Development | Option Exercise | A | 2.43 | 25,000 | 60,750 | 25,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | A | 72.50 | 15,000 | 1,087,500 | 15,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | D | 72.50 | 15,000 | 1,087,500 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | A | 8.00 | 15,000 | 120,000 | 15,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | D | 8.00 | 15,000 | 120,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | A | 72.50 | 10,000 | 725,000 | 10,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | D | 72.50 | 10,000 | 725,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | A | 37.00 | 20,000 | 740,000 | 20,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | D | 37.00 | 20,000 | 740,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | A | 72.50 | 10,000 | 725,000 | 10,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | D | 72.50 | 10,000 | 725,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | A | 8.00 | 15,000 | 120,000 | 15,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | D | 8.00 | 15,000 | 120,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | A | 8.81 | 10,000 | 88,125 | 10,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | D | 8.81 | 10,000 | 88,125 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | A | 37.00 | 20,000 | 740,000 | 20,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | D | 37.00 | 20,000 | 740,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | A | 8.00 | 50,000 | 400,000 | 50,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 8.00 | 50,000 | 400,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | A | 15.75 | 15,000 | 236,250 | 15,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 15.75 | 15,000 | 236,250 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | A | 37.00 | 20,000 | 740,000 | 20,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 37.00 | 20,000 | 740,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | A | 72.50 | 10,000 | 725,000 | 10,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | D | 72.50 | 10,000 | 725,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 72.50 | 10,000 | 725,000 | 10,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 72.50 | 10,000 | 725,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 8.00 | 50,000 | 400,000 | 50,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 8.00 | 50,000 | 400,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 15.75 | 5,000 | 78,750 | 5,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 15.75 | 5,000 | 78,750 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 11.44 | 5,000 | 57,200 | 5,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 11.44 | 5,000 | 57,200 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 72.50 | 15,000 | 1,087,500 | 15,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 72.50 | 15,000 | 1,087,500 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 37.00 | 20,000 | 740,000 | 20,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | D | 37.00 | 20,000 | 740,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, President ... | Option Exercise | A | 8.00 | 100,000 | 800,000 | 100,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, President ... | Option Exercise | D | 8.00 | 100,000 | 800,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, President ... | Option Exercise | A | 12.88 | 75,000 | 965,625 | 75,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, President ... | Option Exercise | D | 12.88 | 75,000 | 965,625 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, President ... | Option Exercise | A | 37.00 | 100,000 | 3,700,000 | 100,000 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, President ... | Option Exercise | D | 37.00 | 100,000 | 3,700,000 | 0 | |
Nov 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | GLEASON PAMELA GEE | VP, Human Resources | Option Exercise | A | 2.43 | 5,000 | 12,150 | 5,000 | |
Oct 20 2004 | MAXM | MAXIM PHARMACEUTIC ... | GLEASON PAMELA GEE | VP, Human Resources | Option Exercise | A | 2.30 | 25,000 | 57,500 | 25,000 | |
Oct 20 2004 | MAXM | MAXIM PHARMACEUTIC ... | TONETTA SHARON A | VP Drug Development | Option Exercise | A | 2.30 | 25,000 | 57,500 | 25,000 | |
Jul 21 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | M | 3.25 | 20,000 | 65,000 | 0 | |
Jul 21 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | M | 3.25 | 20,000 | 65,000 | 0 | |
Jul 21 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Buy | M | 3.25 | 20,000 | 65,000 | 71,228 | 51.2 K to 71.2 K (+39.04 %) |
Jul 21 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Buy | M | 3.25 | 20,000 | 65,000 | 51,228 | 31.2 K to 51.2 K (+64.05 %) |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chairman, CEO and P ... | Option Exercise | A | 8.94 | 125,000 | 1,117,500 | 125,000 | |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Option Exercise | A | 8.94 | 75,000 | 670,500 | 75,000 | |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Option Exercise | M | 2.13 | 60,000 | 127,800 | 65,000 | |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Sell | S | 8.89 | 20,000 | 177,852 | 20,201 | 40.2 K to 20.2 K (-49.75 %) |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Sell | S | 8.89 | 20,000 | 177,836 | 40,201 | 60.2 K to 40.2 K (-33.22 %) |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Sell | S | 8.92 | 20,000 | 178,402 | 60,201 | 80.2 K to 60.2 K (-24.94 %) |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Buy | M | 2.13 | 60,000 | 127,800 | 80,201 | 20.2 K to 80.2 K (+297.01 %) |
Jun 28 2004 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Sell | J | 0.00 | 5,050 | 0 | 20,201 | 25.3 K to 20.2 K (-20.00 %) |
Mar 25 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Buy | J | 0.00 | 1,050 | 0 | 31,228 | 30.2 K to 31.2 K (+3.48 %) |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | ZERBE ROBERT L MD | Director | Option Exercise | A | 9.60 | 20,000 | 192,000 | 20,000 | |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | HEINRICHS THEODOR H | Director | Option Exercise | A | 9.60 | 20,000 | 192,000 | 20,000 | |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | FRASHIER GARY E | Director | Option Exercise | A | 9.60 | 20,000 | 192,000 | 20,000 | |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | A | 9.60 | 20,000 | 192,000 | 20,000 | |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | MARTENSSON PEROLAF | Director | Option Exercise | A | 9.60 | 20,000 | 192,000 | 20,000 | |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | TOWNSEN FULTON DUWAINE | Director | Option Exercise | A | 9.60 | 20,000 | 192,000 | 20,000 | |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | A | 9.60 | 18,750 | 180,000 | 18,750 | |
Feb 19 2004 | MAXM | MAXIM PHARMACEUTIC ... | YETTER WAYNE P | Director | Option Exercise | A | 9.60 | 23,750 | 228,000 | 23,750 | |
Nov 24 2003 | MAXM | MAXIM PHARMACEUTIC ... | STAMBAUGH LARRY G | Chief Executive Off ... | Option Exercise | A | 6.72 | 100,000 | 672,000 | 100,000 | |
Nov 24 2003 | MAXM | MAXIM PHARMACEUTIC ... | GLEASON PAMELA GEE | Vice President, Hum ... | Option Exercise | A | 6.72 | 20,000 | 134,400 | 20,000 | |
Nov 24 2003 | MAXM | MAXIM PHARMACEUTIC ... | ALTIG ANTHONY E | Chief Financial Off ... | Option Exercise | A | 6.72 | 2,352 | 15,805 | 2,352 | |
Nov 24 2003 | MAXM | MAXIM PHARMACEUTIC ... | ALTIG ANTHONY E | Chief Financial Off ... | Option Exercise | A | 6.72 | 12,648 | 84,995 | 12,648 | |
Nov 24 2003 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Option Exercise | A | 6.72 | 25,000 | 168,000 | 25,000 | |
Nov 24 2003 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Option Exercise | A | 6.72 | 25,000 | 168,000 | 25,000 | |
Nov 24 2003 | MAXM | MAXIM PHARMACEUTIC ... | GEHLSEN KURT R | Chief Scientific Of ... | Option Exercise | A | 6.72 | 25,000 | 168,000 | 25,000 |
Page: 1